A Win for Science, with Profound Implications for Industry: FDA Rejects MDMA
Mad in America
AUGUST 14, 2024
That is surely a problem, but it’s also a documented problem for other drugs. Perhaps because MDMA-assisted therapy isn’t a simple drug to be prescribed by psychiatrists. Moreover, Lykos is a small company bringing it to market, one that emerged out of a psychedelic research nonprofit (MAPS).
127 
Let's personalize your content